We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Innov Regulatory News (SEED)

Share Price Information for Seed Innov (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 2.10
Ask: 2.30
Change: 0.15 (7.32%)
Spread: 0.20 (9.524%)
Open: 2.05
High: 2.20
Low: 2.05
Prev. Close: 2.05
SEED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Receipt of remaining £2.4m from sale of Leap

15 Apr 2024 07:00

RNS Number : 5275K
Seed Innovations Limited
15 April 2024
 

15 April 2024 

SEED Innovations Limited 

("SEED" or the "Company")

 

Receipt of remaining circa £2.4m (€2.76m) from the sale of Leap Gaming

 

Strengthens cash position to over £6 million

 

 SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness, and medical cannabis companies, to which, in normal circumstances they have limited access to, is pleased to announce that it has received the remaining circa £2.4m (€2.76m) from the sale of its portfolio company Fralis LLC, trading as Leap Gaming.

 

Leap Gaming was sold in April 2023 (see RNS dated 11 April 2023), with SEED's proceeds of the sale totalling €5.8 million payable in two tranches. The first tranche of €3 million (£2.7m) was received on completion of the deal and the balance was received on the 12 April 2024.

 

The Leap Gaming sale has contributed to SEED's strong cash position of over £6m, which remains higher than its market capitalisation.

 

Commenting on the announcement, Ed McDermott, CEO of Seed said: "With an additional £2.4 million in cash in the bank, our financial position is exceptionally robust. Despite ongoing liquidity challenges in junior stocks, the investment landscape continues to offer compelling opportunities. Accordingly, we are committed to identifying innovative investment opportunities that will benefit our shareholders. Our primary objective is to enhance shareholder value, and we anticipate unveiling several strategic initiatives aimed at achieving this goal in the near future. We are confident that these initiatives will be well-received by our shareholders."

- Ends -

 

 For further information on the Company please visit: www.seedinnovations.co or contact: 

 

 Ed McDermott 

Lance de Jersey 

SEED Innovations Ltd 

E: info@seedinnovations.co

James Biddle 

Roland Cornish 

Beaumont Cornish Limited, 

Nomad 

T: (0)20 7628 3396

Isabella Pierre 

Damon Heath 

Shard Capital Partners LLP 

Broker 

T: (0)20 7186 9927 

Ana Ribeiro

Isabel de Salis

Isabelle Morris 

 

St Brides Partners Ltd, 

Financial PR 

E: info@stbridespartners.co.uk 

 

Notes 

Seed Innovations Ltd is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFXLLFZZLLBBX
Date   Source Headline
30th Apr 20247:00 amRNSTransaction in Own Shares & TVR
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR
26th Mar 20241:03 pmRNSTransaction in Own Shares
26th Mar 20247:48 amRNSInvestee Company Update: Clean Food Group
25th Mar 20243:40 pmRNSTransaction in Own Shares & TVR
25th Mar 20247:00 amRNSTransaction in Own Shares & TVR
21st Mar 202410:25 amRNSTransaction in Own Shares & TVR
21st Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:30 pmRNSInvestee Company Update: Northern Leaf
13th Mar 202412:23 pmRNSTransaction in Own Shares & TVR
12th Mar 202412:19 pmRNSTransaction in Own Shares & TVR
11th Mar 202411:27 amRNSTransaction in Own Shares & TVR
7th Mar 20241:09 pmRNSTransaction in Own Shares
7th Mar 20249:08 amRNSTransaction in Own Shares & TVR
29th Feb 20249:00 amRNSContinuation of Existing Share Buy-Back Programme
20th Feb 20244:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
19th Feb 20247:00 amRNSTransaction in Own Shares & TVR
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares & TVR
8th Feb 20247:00 amRNSTransaction in Own Shares & TVR
7th Feb 20247:00 amRNSTransaction in Own Shares & TVR
5th Feb 20242:00 pmRNSTransaction in Own Shares & TVR
1st Feb 20243:22 pmRNSTransaction in Own Shares & TVR
1st Feb 202410:06 amRNSInvestee Company Update: Little Green Pharma Ltd
26th Jan 20247:00 amRNSTransaction in Own Shares & TVR
25th Jan 20243:03 pmRNSInvestee Company Update: Avextra AG Raises €3.3m
25th Jan 20247:00 amRNSTransaction in Own Shares & TVR
24th Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSTransaction in Own Shares & TVR
22nd Jan 20247:00 amRNSCEO Presenting at Proactive One2One Investor Forum
19th Jan 20246:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.